| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1006/GYNO.1994.1334 |
| P698 | PubMed publication ID | 7835800 |
| P2093 | author name string | Whittemore AS | |
| P433 | issue | 3 Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | S15-9 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Characteristics relating to ovarian cancer risk: implications for prevention and detection | |
| P478 | volume | 55 |
| Q37619184 | A possible link between the pubertal growth of girls and ovarian cancer in their daughters |
| Q28283356 | A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer |
| Q51211236 | An international assessment of ovarian cancer incidence and mortality. |
| Q44221699 | BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases |
| Q35650181 | Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer |
| Q33942835 | Current strategies for prevention, detection, and treatment of ovarian cancer. |
| Q41314826 | Epithelial ovarian carcinoma |
| Q21144976 | Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot" |
| Q47101347 | Expression of Cyclooxygenase-1 and 2 in Epithelial Ovarian Cancer: A Clinicopathologic Study |
| Q34089756 | Health benefits of oral contraceptives |
| Q37354307 | Health effects of breast feeding for mothers: a critical review |
| Q36947246 | Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies |
| Q37753030 | Hormone prevention strategies for breast, endometrial and ovarian cancers |
| Q35828679 | Improved survival in BRCA2 carriers with ovarian cancer |
| Q50991654 | Nodal status--its impact on prognosis in advanced ovarian cancer. |
| Q33747831 | Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium |
| Q34960174 | Potential markers for detection and monitoring of ovarian cancer. |
| Q92067332 | Prevalence, spectrum, and founder effect of BRCA1 and BRCA2 mutations in epithelial ovarian cancer from the Middle East |
| Q36622857 | Recent progress in the diagnosis and treatment of ovarian cancer |
| Q82532746 | Role of prophylactic hysterectomy in patients at high risk for hereditary cancers |
| Q34766184 | Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancer |
| Q37567078 | Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide |
| Q41615167 | The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer |
| Q74730371 | The optimization of breast-feeding in the perinatal period |
| Q45002338 | Traffic air pollution and risk of death from ovarian cancer in Taiwan: fine particulate matter (PM2.5) as a proxy marker |
Search more.